Mount Sinai researchers uncover unique biological markers in patients with mild Crohn’s disease
Peer-Reviewed Publication
Updates every hour. Last Updated: 2-Jan-2026 23:11 ET (3-Jan-2026 04:11 GMT/UTC)
UC Irvine is one of the first two California universities selected for a national program training faculty to integrate evidence-based psychedelic therapy into health education.
Research increasingly supports the use of psychedelics in treating difficult mental health conditions such as depression, anxiety, PTSD and addiction.
A University of Oklahoma researcher is the first to discover that the sequence of the genetic defect in the neuromuscular disease Friedreich’s ataxia isn’t always as uniform as previously thought, a breakthrough finding that could spark changes in how the condition is diagnosed and studied. To further the research, Sanjay Bidichandani, MBBS, Ph.D., a professor of pediatrics at the University of Oklahoma College of Medicine, has received a $2.8 million grant from the U.S. Department of Defense.